COMMUNIQUÉS West-GlobeNewswire

Harvard Bioscience Schedules Second Quarter 2019 Earnings Conference Call for July 25 at 4:30 PM ET
19/07/2019
HOLLISTON, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for the second quarter ended June 30, 2019 after market close on July 25, 2019 and hold a [...]
Retrotope Announces Completion of Series C Preferred Financing and Addition of a Lead Investor on the Board of Directors
19/07/2019
Round co-led by existing inside investors and new outside family office LOS ALTOS, Calif., July 19, 2019 (GLOBE NEWSWIRE) -- Retrotope announced today that it closed a Series C financing, enabling expansion of its [...]
Ossur Hf : Össur acquires College Park Industries
19/07/2019
Reykjavik, 19 July 2019 Össur has signed an agreement to acquire College Park Industries, a global provider of lower and upper limb prostheses and supporting services. College Park has over 140 employees and is [...]
Revive Therapeutics Announces Approval of CSE Listing and Delisting from TSX-V
19/07/2019
TORONTO, July 19, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and [...]
Coherus BioSciences Announces New Employment Inducement Grants
19/07/2019
REDWOOD CITY, Calif., July 19, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective July 18, 2019, the compensation committee of the company’s board of directors granted five [...]
Generex Biotechnology Announces Satisfaction of Debt Obligation
19/07/2019
Retires $3,150,972 in debt and satisfies all associated obligations Payment in GNBT restricted common shares at the July 16, 2019 closing price MIRAMAR, Fla., July 19, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology [...]
Orion Corporation: Managers’ transactions – Virve Laitinen
19/07/2019
ORION CORPORATION MANAGERS’ TRANSACTIONS 19 July 2019 at 15.45 EETS Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
SeaSpine to Report Second Quarter 2019 Financial Results on August 1, 2019
19/07/2019
CARLSBAD, Calif., July 19, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Momenta Pharmaceuticals Announces Date of Second Quarter 2019 Financial Results Conference Call and Webcast
19/07/2019
CAMBRIDGE, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
19/07/2019
ATLANTA, July 19, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal [...]
Minneapolis Based MedTech SubioMed™ Start-Up Gains Certification as a Minnesota Angel Tax Credit Company
19/07/2019
MINNEAPOLIS, July 19, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today [...]
Dova Pharmaceuticals Announces DOPTELET® (avatrombopag) Now Commercially Available in the United States for Treatment of Chronic Immune Thrombocytopenia (ITP)
19/07/2019
DOPTELET Has Differentiated Profile as The Only Oral Thrombopoietin Receptor Agonist (TPO-RA) Approved for Treatment of ITP Without Food Type Restrictions DURHAM, N.C., July 19, 2019 (GLOBE NEWSWIRE) -- Dova [...]
Strongbridge Biopharma plc Announces New Employment Inducement Awards
19/07/2019
DUBLIN, Ireland and TREVOSE, Pa., July 19, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Cynata confirms receipt of indicative, non-binding proposal
19/07/2019
MELBOURNE, Australia, July 19, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP) (“ Cynata ” or, the “ Company ”), a clinical-stage biotechnology company specializing in cell therapeutics, refers to the [...]
Orion Corporation: Managers’ transactions – Timo Lappalainen
19/07/2019
ORION CORPORATION MANAGERS’ TRANSACTIONS 19 July 2019 at 13.15 EETS Orion Corporation: Managers’ transactions – Timo Lappalainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering
19/07/2019
Company Announcement The 15% over-allotment option in connection with Genmab's initial public offering of American Depositary Shares in the United States and listing on the Nasdaq Global Select Market has been exercised [...]
Genmab Announces Submission of Extension of Marketing Authorization to European Medicines Agency for Subcutaneous Formulation of Daratumumab
19/07/2019
Media Release Copenhagen, Denmark; July 19, 2019 Extension of marketing authorization submitted to European Medicines Agency for subcutaneous formulation of daratumumab Submission based on data from Phase III COLUMBA [...]
Motif Bio Announces Receipt of Deficiency Notice from Nasdaq
19/07/2019
NEW YORK, July 19, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that it has received a deficiency [...]
Change in Directors' and PDMR interests in the shares of Acacia Pharma Group plc
19/07/2019
ACACIA PHARMA GROUP PLC Change in Directors' and PDMR interests in the shares of Acacia Pharma Group plc Cambridge, UK and Indianapolis, US –19 July 2019: Acacia Pharma Group plc (“Acacia Pharma”, the "Company”, the “ [...]

Pages